Skip to content

Opening book details…

About this Medicine article

A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function by Siano, M.; Lerch, E.; Negretti, L.; Zucca, E.; Rodriguez-Abreu, D.; Oberson, M.; Leoncini, L.; Mora, O.; Sessa, C.; Gallino, A.; Ghielmini, M. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Siano, M.; Lerch, E.; Negretti, L.; Zucca, E.; Rodriguez-Abreu, D.; Oberson, M.; Leoncini, L.; Mora, O.; Sessa, C.; Gallino, A.; Ghielmini, M.
Publisher
American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
Published
2008
Language
EN
Field
Medicine (Health Sciences)

More by Siano, M.; Lerch, E.; Negretti, L.; Zucca, E.; Rodriguez-Abreu, D.; Oberson, M.; Leoncini, L.; Mora, O.; Sessa, C.; Gallino, A.; Ghielmini, M.

Browse all works by Siano, M.; Lerch, E.; Negretti, L.; Zucca, E.; Rodriguez-Abreu, D.; Oberson, M.; Leoncini, L.; Mora, O.; Sessa, C.; Gallino, A.; Ghielmini, M.